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The mammalian circadian clock is based on a transcription-translation
feedback loop (TTFL) consolidated by secondary loops. In the primary
TTFL, the circadian locomotor output cycles kaput (CLOCK)–brain and
muscle Arnt-like protein-1 (BMAL1) heterodimer acts as the transcrip-
tional activator, and Cryptochrome (CRY) and Period (PER) proteins
function as repressors. PER represses by displacing CLOCK–BMAL1
from promoters in a CRY-dependent manner. Interestingly, genes
with complex promoters may either be repressed or de-repressed
by PER, depending on the particular promoter regulatory elements.
Here, using mouse cell lines with defined knockout mutations in clock
genes, RNA-seq, ChIP-seq, and reporter gene assays coupled with
measurements of DNA–protein interactions in nuclear extracts, we
elucidate the dual functions of PER as repressor and de-repressor in
a context-dependent manner.
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The circadian clock is the molecular system that confers a ∼24-hperiodicity to many biological processes. In mammals, CLOCK,
BMAL1, Cryptochrome (CRY), and Period (PER) proteins and
their paralogs are essential for generating rhythmicity (1–4). Rhyth-
micity is the product of a transcription-translation feedback loop
(TTFL): The circadian locomotor output cycles kaput (CLOCK)–
brain and muscle Arnt-like protein-1 (BMAL1) heterodimer binds to
E-boxes in the promoters of Cry1, Cry2, Per1, and Per2 genes and
activates their transcription. The CRY and PER proteins, after a
time lag, enter the nucleus and inhibit their own transcription (core
clock circuit) (5–9), as well as transcription of other clock-controlled
genes to maintain rhythmicity at the cellular and organismal levels.
This core circuit is consolidated and stabilized by the nuclear re-
ceptors NR1D1 and NR1D2 (REV-ERBα/β), which bind to the
retinoic acid response elements (RREs) in some of the clock gene
promoters (10–14). Although the canonical model has provided a
useful conceptual framework, it has been insufficient in constructing a
mechanistic model for the clock. This is in part due to the multiple
interactions among clock proteins and to the lack of an in vitro sys-
tem for analyzing the clock using purified proteins and their target
promoter elements along with an appropriate readout.
To simplify the analysis of clock protein functions, previously we
reported the construction of cell lines that lack CRYs, PERs, and
both CRYs and PERs and that express ectopic CRY or PER that can
be targeted to the nucleus in a controllable manner (15). Using this
system initially, we analyzed the canonical clock model by restricting
our experiments to the Nr1d1 and D-site albumin promoter binding
protein (Dbp) genes, which are controlled solely by the binding of
CLOCK–BMAL1 to E-box regulatory elements. These experiments
confirmed the repressor functions of CRY and PER but also
revealed some features of their mechanisms: CRY alone can bind to
the CLOCK–BMAL1–E-box complex and inhibit the transcription of
cognate genes by forming a stable CRY–CLOCK–BMAL1 ternary
complex in the promoter: “blocking-type” repression. In contrast,
PER represses CLOCK–BMAL1–E-box-mediated transcription by
removing the CLOCK–BMAL1 complex from the E-box in a CRY-
dependent manner: “displacement-type” repression (15). Although
these findings clarified the roles of PERs and CRYs in regulation
of simple promoters exclusively controlled by E-box binding of
transcription factors, they did not address the issue of the
control of key clock genes with multiple cis-elements.
Here, we report the construction of cell lines with clock gene
knockout mutations and expression systems to analyze the mecha-
nisms of control of more complex promoters by PER2 protein. We
show that the removal of CLOCK–BMAL1 from promoters affects
gene expression in three different ways, depending on the type of
regulatory elements present in the target promoters. First, in the case
of a simple promoter controlled exclusively by an E-box, such as in
the Nr1d1 gene, CLOCK–BMAL1 removal represses transcription.
Second, in genes such as Bmal1, which is controlled exclusively by an
RRE, CLOCK–BMAL1 removal from theNr1d1 promoter indirectly
activates transcription of Bmal1 by down-regulation of NR1D1/2,
which represses by binding to the RRE in the Bmal1 promoter.
Third, in the case of the Cry1 gene, removal of CLOCK–BMAL1
facilitates transactivation by other transcription factors that bind to
the Cry1 promoter independently of NR1D1/2.
Results
Experimental System to Analyze the Role of PER in the TTFL. In Fig. 1
we present a highly idealized model for the mammalian circadian
clock: The CLOCK–BMAL1 heterodimer activates transcription of
Cry1/2, Per1/2, and Nr1d1/2 by binding to E-box (CACGTG/T) se-
quences in the promoters of these genes. The CRY and PER
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proteins inhibit transcriptional activation by CLOCK–BMAL1 to
close the feedback loop, CRY by binding to the CLOCK–
BMAL1–E-box and interfering with transactivation, and PER by
causing the displacement of CLOCK–BMAL1 from E-boxes in a
CRY-dependent manner. This primary circuit is consolidated by a
stabilizing loop: The Nr1d1/2 nuclear receptor genes are also con-
trolled by CLOCK–BMAL1, and NR1D1/2 proteins in turn repress
Bmal1 and Cry1 transcription by binding to the RRE elements in
the promoters of these genes (12–14, 16, 17). Some observations,
such as the repressor activity of CLOCK–BMAL1 (18, 19) and the
apparent transcriptional up-regulation by PER (20–23), do not
readily fit into this model and require further experimentation.
Because there is no in vitro system to analyze the roles of different
clock proteins, individually or in various combinations, on transcrip-
tion of cognate genes, we developed cell lines with various clock gene
knockout mutations (Table S1) and with the controllable PER2 nu-
clear entry system shown in Fig. 2A for carrying out “in cellulo bio-
chemistry” for better insight into the clock mechanism. These cell
lines were isolated from knockout mouse strains or from mouse
embryonic fibroblasts by using transcription activator-like effector
nuclease (TALEN) and CRISPR technologies. The cell lines also
ectopically express PER2-ER*, which is composed of PER2 protein
fused to a mutant form of the ligand-binding domain of the es-
trogen receptor (ER*). PER2-ER* is trapped in the cytoplasm, and
it enters the nucleus upon 4-hydroxytamoxifen (4-OHT) treatment.
Thus, the effect of PER2 on gene expression can be analyzed in a
controllable manner as shown in Fig. 2B. As previously reported
(15), PER2 and CRY1 enter the nucleus together in this system.
PER2 as a Repressor and Antirepressor.We addressed the regulatory
roles of PER using a PER2-ER* ectopic expression system in cells
with various clock gene knockout mutations. We analyzed tran-
scription of three genes selected for their different promoter
complexities, and reported differences in their regulation by PER2
(9–13). The plots in Fig. 3A show the levels of mRNA expressed
from the Nr1d1, Bmal1, and Cry1 genes in Per1/2−/− cells following
0–6 h of treatment with 4-OHT, which induces translocation of
PER2-ER* to the nucleus. The Nr1d1 promoter is controlled
solely by an E-box, the Bmal1 promoter is controlled solely by the
RRE element, and the Cry1 promoter is controlled by an E-box, an
RRE element, and a D-box (14). As expected (15), the data in Fig.
3A (PER2-ER* enters the nucleus of Per1/2−/− cells) show that
PER2 inhibits transcription of Nr1d1 (by removing CLOCK–
BMAL1 from the E-box; Fig. 3A, Left, red); however, PER2 also
induces transcription of Bmal1 and Cry1 (Fig. 3A,Middle and Right,
red). Because PER2 inhibits the expression of Nr1d1 and because
both Bmal1 and Cry1 have RRE elements in their promoters to
which NR1D1/2 binds (12–14, 16, 24), it has been suggested that
PER2 de-represses genes by down-regulating the NR1D1 repressor.
To test this prediction, we investigated the effect of Nr1d1/2 dele-
tions on PER2-ER*–mediated up-regulation of Bmal1 and Cry1
transcription. In the absence of NR1D1/2, there is no up-regulation
of Bmal1 transcription by PER2-ER* (Fig. 3A, Middle, blue), sup-
porting the view that PER2 up-regulates Bmal1 by down-regulating
NR1D1/2. In contrast, and surprisingly, the NR1D1/2 deletions
have no effect on PER2-mediated up-regulation of Cry1 (Fig. 3A,
Right, blue). This agrees with the observation that NR1D1/2 is
dispensable for the rhythmic expression of Cry1 (12) and indicates
Fig. 1. TTFL model for the mammalian circadian clock. In the TTFL model,
CLOCK–BMAL1 heterodimers bind to the E-boxes of Cry1/2, Per1/2, and
Nr1d1/2 promoters and activate the transcription of these genes. Increased
CRY protein then inhibits transcription through binding to the CLOCK–
BMAL1 complex. PER protein inhibits transcription in a CRY-dependent
manner by reducing CLOCK–BMAL1 binding to the E-box. This core circuit
(solid lines) is stabilized by a secondary feedback loop (dashed lines) in which
CLOCK–BMAL1-controlled NR1D1/2 inhibits the transcription of Bmal1 and
Cry1 through binding to the RRE of their promoters.
Fig. 2. Cell-based system for study of mammalian clock regulation. (A) Sche-
matic of the experimental system. PER2 fused to a mutant form of the estrogen
receptor ligand-binding domain (ER*) is constrained to the cytosol when bound
to endogenous heat-shock protein (HSP). Addition of 4-OHT to the cell culture
displaces the HSP, and PER2-ER* then enters the nucleus. (B) Immunoblot analysis
of clock proteins upon 4-OHT addition. Total and nuclear amounts of clock and
control proteins (MEK2 and LaminA, which is a nuclear protein) up to 6 h fol-
lowing addition of 4-OHT to Per1/2−/−;PER2-ER* cells are shown. The blot shows
that the total NR1D1 protein level (and thus nuclear NR1D1) decreases following
incubation with 4-OHT. An increased level of nuclear CRY1 but not total CRY1 is
associated with the increased nuclear PER2. This supports the idea that CRY and
PER enter the nucleus together and that CRY-dependent PER2 activity is through
the formation of a CRY–PER complex. NR1D1.s and NR1D1.L are short and long
exposures of the same blot.
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that PER2 up-regulates Cry1 transcription by a mechanism inde-
pendent of NR1D1/2.
PER2 Repressor and Antirepressor Activities Are BMAL1- and CRY-
Dependent. Based on indirect evidence, it has been previously
reported that PER2 can up-regulate gene transcription by interacting
with another transcription factor (25) or by removing CRY from
CLOCK–BMAL1 (20). We have shown that PER2 represses tran-
scription by removing the CLOCK–BMAL1 complex from cognate
promoters in a CRY-dependent manner (15). We wished to know if
the transcriptional up-regulation effect of PER was also mediated
through removal of the CLOCK–BMAL1–CRY complex. To this
end, we tested the effect of PER2-ER* nuclear entry on transcription
of the three sentinel genes in cells lacking BMAL1. In these Bmal1
knockout cells, endogenous PER2 is undetectable (4), and thus any
effect that might be seen upon 4-OHT addition can be ascribed to
PER2-ER*. The results (Fig. 3A, orange) show that in the absence of
BMAL1 there is no repression or de-repression of these genes upon
nuclear entry of PER2-ER*. This excluded the possibility that PER2
facilitates a transcriptional activator in a BMAL1-independent
manner to activate Cry1 transcription. To examine whether PER2-
induced up-regulation is dependent on CRY proteins, we tested the
effect of PER2-ER* on expression of all three sentinel genes in cells
lacking CRY1/2. As seen in Fig. 3A, the effect of PER2 on all these
three genes (red) is abolished in the Cry1/2 knockout background
(green), indicating that PER2 exerts its up-regulation activity only
through a CRY-mediated mechanism as it does its repressor activity.
Gene Up-Regulation by PER2 Is Associated with Removal of CLOCK–
BMAL1. We then used ChIP to directly examine the binding of
BMAL1 to the sentinel gene promoters in response to PER2. In Fig.
3B,Middle, there is no BMAL1 binding to the Bmal1 promoter, as it
lacks an E-box (1, 2, 4). Fig. 3B, Left shows that, as expected, nuclear
entry of PER2 following 4-OHT treatment causes displacement of
BMAL1 from the (PER2-repressed) Nr1d1 promoter (red), and this
displacement is NR1D1/2-independent (blue) but CRY-dependent
(green). Importantly, the positive regulation of the (PER2-activated)
Cry1 promoter shown in Fig. 3A, Right coincides with NR1D1/2-
independent but CRY-dependent displacement of BMAL1 (Fig.
3B, Right). Taken together, these data indicate that BMAL1 and
CRY are required for both PER-mediated transcriptional repres-
sion and up-regulation in a context-dependent manner. Indeed, the
idea of repression by CRY in a CLOCK–BMAL1-dependent
manner was suggested in a previous study, although there was no
direct experimental evidence (19). We suggest that in the Cry1
promoter, CLOCK–BMAL1 binding to an E-box represses another
activator, which is the predominant transcription activator for this
gene. Here, we show that the PER2-mediated up-regulation of Cry1
gene transcription is accompanied with the removal of the CLOCK–
BMAL1–CRY complex from the Cry1 promoter and thus present
Fig. 3. Effect of PER2 nuclear entry on transcription of Nr1d1, Bmal1, and Cry1 in Per1/2−/−, Per1/2−/−;Nr1d1/2−/−, Per1/2−/−;Cry1/2−/−, and Bmal1−/− cells. (A) Nuclear
entry of PER2-ER* following addition of 4-OHT (red) represses Nr1d1 transcription (Left) but induces Bmal1 (Middle) and Cry1 (Right) transcription analyzed by
RT-quantitative PCR. The effect of PER2 on these three genes is CRY-dependent (green). NR1D1/2 is required for PER2-induced Bmal1 transcription but is not required
for the repression of Nr1d1 or for the induction of Cry1 transcription (blue). In Bmal1−/− cells (orange), nuclear entry of PER2-ER* has no effect on Nr1d1, Bmal1, or
Cry1 transcription. Endogenous PER2 was not detected in Bmal1−/− cells (4). (B) PER2-dependent, CRY-dependent, NR1D1/2-independent displacement of CLOCK–
BMAL1 from Nr1d1 and Cry1 E-boxes is analyzed by BMAL1–ChIP–quantitative PCR. Bmal1, which has no E-box and is not a primary target of CLOCK–BMAL1, is a
negative control for ChIP. SE values are displayed in A and B.
E6074 | www.pnas.org/cgi/doi/10.1073/pnas.1612917113 Chiou et al.
direct evidence for these counterintuitive roles of CLOCK–BMAL1
in gene repression and PER2 (with CRY) in gene de-repression.
Genome-Wide Effect of PER on Regulation and Promoter Binding by
the CLOCK–BMAL1 Complex. The model that emerges from the results
presented here as well as our previous studies is that PER displaces
CLOCK–BMAL1 from cognate gene promoters and in doing so,
depending on the complement of regulatory elements in the target
promoter, it either inhibits or up-regulates (de-represses) transcrip-
tion in a CRY-dependent manner (15). Because there are several
thousands of CLOCK–BMAL1 binding sites in the genome (26, 27),
we wished to find out whether PER-mediated CLOCK–BMAL1
removal and both the repression and de-repression functions of PER
are observed on a global scale. To this end, we performed ChIP-seq
experiments using an anti-BMAL1 antibody to probe CLOCK–
BMAL1 binding sites and RNA-seq experiments to analyze RNA
levels before and after nuclear entry of PER2 in Per1/2−/−;Nr1d1/2−/−;
PER2-ER* cells so as to avoid complications arising from second-
order clock-controlled genes regulated by NR1D1/2 (such as Bmal1).
ChIP-seq experiments were conducted in duplicate with cells not
treated with 4-OHT. Specific BMAL1 binding sites were identified
based on 10–15 million input and precipitated DNA reads (Materials
and Methods). There were 4,789 and 8,615 binding sites in the two
experiments and 4,740 common binding sites seen in both experi-
ments. Induction of PER2 with 4-OHT reduced the number of
common BMAL1 binding sites to 483, and PER2 induction pro-
duced no novel BMAL1 binding sites. Thus, PER2 eliminated de-
tectable binding of BMAL1 to most of the regulatory regions to
which it binds. To further assess BMAL1 binding, we analyzed reads
mapped to the 4,740 common BMAL1 binding sites as relative
BMAL1 binding strength, expressed as “IP/input.”We observed that
relative BMAL1 binding strength was negatively associated with
PER2 induction and was highly correlated between the two inde-
pendent experiments (Fig. 4A, Left). BMAL1 binding was stronger
without 4-OHT than with 4-OHT on almost all regions (Fig. 4A,
Right). To determine whether the observed decrease in BMAL1
binding was due to experiment-specific technical factors such as se-
quencing depth, we compared binding differences from these
BMAL1 binding sites to reads randomly selected from the genome.
Relative to the BMAL1 binding sites, there is no difference of
BMAL1 binding between without 4-OHT and with 4-OHT in the
random areas (Fig. 4B). Results of motif analysis of the BMAL1
binding sites showed high enrichment of the E-box sequence (Fig.
4C), which further supports the finding that PER2 removes
CLOCK–BMAL1 from the E-box sequence of the promoters.
To analyze the effect of PER2 on CLOCK–BMAL1-controlled
gene expression, we first defined CLOCK–BMAL1-controlled genes
as genes with transcription start sites within ±5 kb from BMAL1
binding sites. Based on our ChIP-seq data, 3,317 genes were selected
for the analysis. As apparent from the volcano plot in Fig. 5, nuclear
entry of PER2-ER* changes the expression pattern, with 53 transcripts
going down, 28 going up, and most remaining unchanged (Table S2).
Interestingly, Cry1 and Cry2 are increased and Nr1d1 and Nr1d2 are
decreased when PER2 enters the nucleus. To ascertain the quality of
the data from BMAL1 ChIP-seq and RNA-seq, in Fig. 6 we focus on
Cry1 and Nr1d1 loci, on chromosomes 10 and 11, respectively: In
agreement with the RT-quantitative PCR and ChIP-quantitative PCR
data in Fig. 3, nuclear entry of PER2 up-regulatesCry1 expression and
represses the Nr1d1 transcript level and both are associated with a
decrease in BMAL1 binding on the promoter. Similarly, increased
Cry2, Dec1 (Bhlhe40), and decreased Nr1d2 transcription (Table S2)
are confirmed by RT-quantitative PCR (Fig. S1).
Decreased CLOCK–BMAL1 Binding on the Cry1 Promoter Increases
Cry1 Transcription. Finally, the experiments described so far were
carried out with 4-OHT–induced nuclear entry of PER2-ER*, and
it could be argued that in this model system, the observed removal
of CLOCK–BMAL1 from promoters and the accompanying
up-regulation of Cry1 might be due to some unique feature of our
system and that the CLOCK–BMAL1 removal from the E-box
upon PER2-ER* nuclear entry and Cry1 up-regulation might not
be physiologically relevant. To address this issue, we conducted
reporter gene assays using a 1.5 kbp promoter fragment of Cry1,
which can sustain rhythmic transcription (14). This fragment pos-
sesses two D-box and two E-box sequences that partially overlap, as
shown in Fig. 7A. To characterize the effect of CLOCK–BMAL1
binding on Cry1 transcription, we first compared the reporter ac-
tivity of Cry1 promoters with either wild-type (WT) or mutant
E-box (mutE) sequences (Fig. 7A). In a preliminary control exper-
iment to ascertain the specificity of CLOCK–BMAL1 binding to the
E-box in the Cry1 promoter, the two 1.5 kbp promoter fragments,
end-labeled with biotin, were incubated with NIH 3T3 cell-free
extract. The fragments were pulled down and the bound BMAL1
was visualized in the Western blot shown in Fig. 7B. BMAL1 bound
to the WT promoter but only weakly to the mutant promoter.
Reporter assays were then performed following cotransfection
of the Cry1 promoter/reporter constructs with and without PER2
and/or CRY1-expressing plasmids, which is a commonly used
circadian experimental system. Fig. 7C, lane 1 shows that in the
absence of exogenous PER2 or CRY1, there was much more
expression from the mutE (green) than the WT (red) promoter.
This increase is consistent with strong transcription from another
element on the 1.5 kbp fragment that is inhibited by CLOCK–
BMAL1–CRY1 binding to the WT E-box. Expression of PER2 led
to substantially increased transcription from the WT promoter
fragment (lanes 2 and 3). Apparently the basal level of CRY1/2 in
these cells is sufficient to enable the removal of CLOCK–BMAL1
Fig. 4. Effect of PER2 nuclear entry on BMAL1 promoter binding by BMAL1–
ChIP-Seq in Per1/2−/−;Nr1d1/2−/− cells. (A) Strength of BMAL1 binding (ChIP/Input)
to 4,740 common binding sites is shown as a scatter plot. (Left) Results with
(green) and without (red) 4-OHT show high correlation between the two ex-
periments. The results obtained with 4-OHT are closest to the origin, indicating
weak or no binding of BMAL1 following PER2 induction. (Right) The strength of
BMAL1 binding in the condition with (x axis) and without (y axis) 4-OHT is
plotted. The distributions largely overlap in the two experiments and are above
the line representing y = x, indicating reduced BMAL1 binding following PER2
induction. (B) Distribution of relative strength of BMAL1 binding –4-OHT/+4-OHT
was plotted by violin and box plot. Stronger binding of BMAL1 without 4-OHT
was detected on the BMAL1 binding sites (red) but not with reads randomly
selected from the genome (blue). (C) Result from motif analysis of BMAL1
binding sites shows strong enrichment of the E-box sequence.
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by exogenous PER2 so as to reveal strong transcription. A modest
increase in transcription of the mutE promoter by exogenous PER2
is consistent with the removal of residual CLOCK–BMAL1 bound
weakly to the mutant promoter (green, lane 1 vs. lanes 2 and 3).
Comparing lane 4 versus lane 1 (red) shows that exogenous CRY1
inhibited transcription mediated by CLOCK–BMAL1. Increasing the
amount of exogenous PER2, in the presence of exogenous CRY1
(lanes 5–8), resulted in increased transcription, as PER2 removed
CLOCK–BMAL1 from the E-boxes in a CRY1-dependent
manner. These data from cellular oscillators support our conclusion
that up-regulation of Cry1 by PER2 is not simply due to removal of
CRY1 to facilitate CLOCK–BMAL1-mediated transcription but in
fact is due to the removal of the entire CRY1–CLOCK–BMAL1
“repressor complex” to facilitate the activation of transcription by
another sequence element in the 1.5 kbp Cry1 promoter region.
It has been shown that Cry1 transcription could be regulated
through the D-box in the promoter (14). It is possible that removal
of CLOCK–BMAL1 from the E-boxes by PER facilitates the
transcription of Cry1 through the nearby and overlapping D-boxes
(Fig. 7A). We considered that D-box binding proteins, such as DBP,
TEF, and HLF, would activate the transcription of Cry1 when not
blocked by the binding of CLOCK–BMAL1–CRY to the E-boxes.
To test this, we measured the reporter activity of a Cry1 promoter
with mutated D-box and E-box (mutDE, Fig. 7A). As seen with the
mutE promoter, mutDE promoter activity in the absence of exog-
enous PER2 or CRY1 was much higher than WT (lane 1, blue) and
furthermore was very similar to mutE in all conditions tested. Thus,
the increase in Cry1 transcription mediated by PER as a result of
CLOCK–BMAL1 dissociation is not by removal of a repressor
complex interfering with D-box–mediated activation. It is most
likely that another transcriptional activator with a binding site in
the 1.5 kbp Cry1 promoter fragment is responsible for increased
Cry1 expression following removal of CLOCK–BMAL1. For pur-
poses of discussion, this possible transcription factor will be referred
to as factor T, which binds to a postulated T element in the Cry1
promoter (Fig. 8).
Discussion
The mammalian molecular circadian clock consists of a TTFL
generated by four genes (core clock genes) and their paralogs.
Research over the past two decades has supported the TTFL
model and identified a secondary loop involving nuclear recep-
tors Nr1d1/2. Furthermore, identification of kinases (28, 29) and
ubiquitin ligases (30, 31) that modulate the activity and stability
of the core clock proteins has provided insights into the mech-
anisms that are necessary to establish a daily rhythm of high
amplitude, precise period, and flexibility for phase resetting in
response to stimuli.
Despite these important developments, the negative arm of the
TTFL model has remained poorly defined. In particular, the re-
spective roles of CRY and PER in repression have been unclear.
There are several reasons for this uncertainty. First, the two pro-
teins interact strongly and aid in one another’s stability and nuclear
entry (32–34). Second, removal of one affects the posttranslational
modification and stability of the other. Also, although CRY has
been shown to be capable of repressing target genes on its own,
there is no convincing evidence that PER affects the TTFL in the
absence of CRY (15). Moreover, depending on the clock gene
tested, PER has been reported to function as either a repressor (for
Nr1d1) or an up-regulator (for Cry1 and Bmal1).
To examine the clock model, we have developed an “in cellulo
biochemical” system consisting of mouse cell lines with knockout
mutations in one or more of the core clock genes and that have a
controllable delivery system for CRY or PER proteins (15). In
Fig. 5. Effect of PER2 nuclear entry on transcriptome by mRNA-Seq in Per1/
2−/−;Nr1d1/2−/− cells. Effect of PER2 nuclear entry on transcription of indi-
vidual genes is shown by Volcano plot with the x axis representing level of
difference (+4-OHT vs. –4-OHT) and the y axis representing the level of
statistical significance. Genes with a statistically significant difference be-
tween with and without 4-OHT are shown in red.
Fig. 6. Visualization of BMAL1–ChIP-seq and RNA-seq on Nr1d1 (Top) and Cry1
(Bottom) gene loci. (Top) An 11 kbp region of chromosome 11 containing the
Nr1d1 gene. (Bottom) A 57 kbp region of chromosome 10 containing the Cry1
gene. Gene structures are illustrated along the x axis beneath each panel, with
E/E’-box regulatory elements indicated with green asterisks. Within each panel,
the magnitude of the ChIP-seq signal (y axis) is shown in the top half, and the
magnitude of the RNA-seq signal (y axis) is shown in the bottom half. Signals
observed with 4-OHT are shown in red, and signals without 4-OHT are shown in
blue. With both genes, lower ChIP-seq signals were observed with 4-OHT (red)
than without 4-OHT (blue). However, following induction of PER2 with 4-OHT,
RNA-seq data show a weaker signal in the Nr1d1 gene and a stronger signal in
the Cry1 gene. Data were visualized using IGV software.
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this study, using the PER2 delivery system, we have obtained
RT-quantitative PCR, RNA-seq, ChIP, and ChIP-seq data that
have enabled us to revise the consensus mammalian clock model
so as to reconcile various views regarding the roles of CRY and
PER in the negative arm of the TTFL and eliminate the “internal
inconsistencies” of the conventional model (3).
We previously reported that PER causes the removal of
CLOCK–BMAL1 from the cognate promoters in a CRY-
dependent manner and that it inhibits the transcription of certain
genes with simple promoters (promoters with only an E-box
control element) by this mechanism. In this study, we investigated
the effect of PER2 on transcription of genes with more complex
promoters. In aggregate, our work shows that PER2 exerts three
types of effect on clock gene transcription, depending upon the
type of promoter. Furthermore, we show that all of these effects
are CRY-dependent, and moreover our data reconcile some
previous seemingly contradictory reports on PER function in the
circadian clock. We explain the three different effects of PER2 on
circadian gene expression as follows:
i) Nr1d1 (repressed by PER2): This gene is predominantly regu-
lated by an E-box. Binding of CRY1 (or CRY2) to the CLOCK–
BMAL1–E-box complex represses transcription. When PER2 is
abundant enough, it removes the CRY1–CLOCK–BMAL1
complex from the promoter as part of the dual repression
mechanism of CRY and PER (15).
ii) Bmal1 (de-repressed by PER2): This gene is predominantly
regulated by NR1D1/NR1D2 nuclear receptors; CRY1/CRY2
de-repress its transcription. We show that de-repression is
through the effects of CRY1/2 and PER1/2 on NR1D1/
NR1D2 expression. When CRY and PER are at high enough
concentrations, they inhibit NR1D1/NR1D2 expression
through the E-box and thus down-regulate the repressors of
Bmal1 causing up-regulation of Bmal1 transcription. Knockout
of Nr1d1/Nr1d2 eliminates the effect of CRYs and PERs on
Bmal1 transcription, which is mediated by NR1D1/NR1D2.
iii) Cry1 (de-repressed by PER2): This gene has several transcrip-
tional elements, three of which have been studied previously—
D-box (day element), E-box (morning element), and RRE
(evening element)—which are the targets of transcription fac-
tors DBP, CLOCK–BMAL1, and NR1D1/NR1D2, respectively
(14). Up-regulation (de-repression) of the Cry1 promoter by
PER2 seen in our experiments is not consistent with the ac-
cepted role of PER2 as a repressor. Kondratov et al. (19) and
Liu et al. (12) observed related, unexpected results, namely the
up-regulation of Cry1 in Bmal1 knockout cells. Kondratov et al.
(19) suggested that with some genes, such as Cry1, there is a
high “basal” level of transcription that is not substantially in-
creased by CLOCK–BMAL1 binding to the promoter, and
binding of CRY1 to the CLOCK–BMAL1 complex inhibits
both CLOCK–BMAL1 activated and basal transcription. In
this vein, our findings are consistent with the existence of an
additional transcriptional activator (factor T) that binds to a
regulatory element (T element) in the Cry1 promoter (12) and
Fig. 7. Decreased CLOCK–BMAL1 binding increases reporter gene expres-
sion driven from the Cry1 promoter. (A) Sequences of the Cry1 promoter
region including WT, mutant E-boxes, and D-boxes are shown. Nucleotides
conserved in the E-box and D-box sequences are colored in green and blue,
respectively. Nucleotides mutated in mutE (E-box mutation) and mutDE
(D-box and E-box mutation) are colored in red. (B) CLOCK–BMAL1 binding
affinity to Cry1 promoters with WT or mutE sequences. BMAL1 was pulled
down from nuclear extract from NIH 3T3 cells by immobilized biotin–DNA
and analyzed by Western blot. (C) Reporter gene assay of the Cry1 pro-
moters with the WT or mutant promoter elements is shown. Reporter signals
were first normalized to the signals from cotransfected control plasmid and
then were normalized to the condition without Cry1 and Per2 plasmids. Note
that reporter gene expression driven by the mutant Cry1 promoter is higher
than expression driven by the WT Cry1 promoter. SEs are plotted in C.
Fig. 8. Model of PER-mediated regulation of Nr1d1, Bmal1, and Cry1 genes.
This model represents transcription and regulation patterns of the Nr1d1,
Bmal1, and Cry1 genes individually as a function of the circadian time. Gradient-
colored bars represent transcription of Nr1d1 (blue), Bmal1 (orange), and
Cry1 (green) genes based on nascent RNA-seq data from mouse liver (27).
Above the bars are the proposed status of promoter occupation and tran-
scription. Spacing of the T element, E-box, and RRE in this representation of
the Cry1 promoter is for illustrative purposes only. The RRE element is in
intron 1 of Cry1 ∼23 kbp downstream from the E-box. At the bottom of the
model are the levels of NR1D1, CRY1, and PER2 in mouse liver nuclei. The
levels of these and additional proteins from different times were cropped
from a single image (Fig. S2). For Nr1d1, which is controlled solely by an
E-box, transcription is inhibited by either binding of CRY on CLOCK–BMAL1
or removal of CRY1–CLOCK–BMAL1 from the E-box by PER. For Bmal1,
which is controlled solely by an RRE, transcription is inversely correlated
with the NR1D1 level. For Cry1, which is controlled by an E-box, RRE, and a
putative factor T, binding of either the CRY–CLOCK–BMAL1 complex on the
E-box or NR1D1 on the RRE represses the transcription of Cry1 from another
element (T). PER eliminates both pathways of inhibition by removing
CLOCK–BMAL1 from the E-box.
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is inhibited by the CRY1–CLOCK–BMAL1 complex. In this
scenario, removal of CRY1-CLOCK-BMAL1 from the Cry1
promoter by PER2 restores transcription via factor T.
Regarding the elevated Cry1 level in the Bmal1 knockout cells,
Liu et al. (12) hypothesized that the absence of BMAL1 led to
less NR1D1/NR1D2, which normally binds to the RRE element
and represses transcription of Cry1. In fact, in their experiments,
overexpression of NR1D1 in Bmal1 knockout cells did inhibit
Cry1 expression. Thus, their interpretation of BMAL1 indirectly
inhibiting Cry1 expression through NR1D1/NR1D2 appears ap-
propriate to their defined experimental system, and it is reasonable
to expect that NR1D1/NR1D2 influence Cry1 expression in vivo.
However, our cell-based (Fig. 3) and reporter assay (Fig. 7) data
show that PER2-mediated expression of Cry1 is independent of
NR1D1 (our reporter lacked the NR1D1 binding site). These
seemingly conflicting results are reconciled and incorporated in the
revised clock model shown in Fig. 8, which also shows levels of
NR1D1, CRY1, and PER2 proteins in mouse liver at various cir-
cadian times. At ZT10, NR1D1 is high and it likely represses Cry1
by binding to the RRE element, whereas at ZT18 NR1D1 is low,
and this likely contributes to initiate Cry1 expression. Also, at ZT18,
PER2 is high and PER2 at this time likely helps initiate Cry1
transcription by removing the inhibitory CRY1–CLOCK–BMAL1
complex. Thus, in this model, PER2 has dual roles in regulation of
Cry1. First, through displacement of CRY–CLOCK–BMAL1 from
the Nr1d1/Nr1d2 promoters, it represses NR1D1/NR1D2 and thus
indirectly activates Cry1 expression. Second, through displacement
of CRY–CLOCK–BMAL1 from the Cry1 promoter, it directly de-
represses Cry1 expression.
We note that our findings contradict a recent report (20) that
claimed that PER2 up-regulates Cry1 transcription by removing
CRY1 from the CRY1–CLOCK–BMAL1 complex at the Cry1
E-box and at the E-boxes of other genes regulated by CLOCK–
BMAL1. Here, we confirm our earlier finding (15) that in fact
PER2 nuclear entry causes the removal of CLOCK–BMAL1
from the Cry1 promoter in a CRY-dependent manner while at
the same time up-regulating Cry1 transcription.
Because the D-box in the Cry1 promoter has been shown to
play a role in Cry1 regulation, we considered transcription factors
(DBP, TEF, and HLF) that bind to the D-box as potential Cry1
transcriptional activators when PER2 removes the CRY–CLOCK–
BMAL1 complex from the Cry1 promoter. We tested this possibility
by using reporter gene assays with a 1.5 kbp fragment carrying the
Cry1 promoter including the D-box and E-box elements. As
expected, in this system, CRY1 repressed and PER2 together with
CRY1 de-repressed transcription of Cry1. MutE and double mutant
E-box/D-box constructs, with greatly reduced CLOCK–BMAL
binding, demonstrated reduced transcription stimulation following
PER2 induction. Thus, DBP cannot be factor T whose activity is
revealed by dissociation of the CRY1–CLOCK–BMAL1 complex.
Additional studies are needed to identify the postulated T element
and T factor that acts in a tonic manner (12) to regulate Cry1
transcription and whose effect is rendered circadian in the context
of the entire circadian ensemble.
Materials and Methods
Cells and Antibodies. Cell lines (Table S1) were maintained in DMEM
supplemented with 10% (vol/vol) FBS in 5% (vol/vol) CO2 at 37 °C. Blasticidin
(5 μg/mL) was present during cell culture and absent during experiments. To
induce PER2-ER* nuclear entry, 4-hydoxytamoxifen was added to the medium
to 1 μM when cells were ∼90% confluent.
The Bmal1−/−, Per1/2−/−, and Cry1/2−/−;Per1/2−/− mouse embryonic fibro-
blasts have been described (15, 32). The Per1/2−/−;Nr1d1/2−/- mouse embry-
onic fibroblast cell line was made by CRISPR technology using LentiCRISPRv2
(35) obtained from Addgene to mutate the Nr1d1/2 alleles in Per1/2−/− fi-
broblasts. Single colonies lacking NR1D1/2 proteins were isolated and
screened by Western blot, and mutational inactivation was confirmed by
genomic DNA sequencing. Mutated sequences in the isolated clone (PN-P2ER)
are shown in Fig. S3. Lack of NR1D1/2 protein and movement of PER2-ER* to
the nucleus are shown in Fig. S4.
DNA containing mPER2-ER* was subcloned from pBABE-puro-mPER2-ER*
into plasmid pWZL-blast to create pWZL-blast-mPER2-ER*. Cells stably
expressing P-P2ER, PN-P2ER, and B-P2ER were made by retrovirus infection
using pWZL-blast-mPER2-ER* (15).
Anti-mCRY1 (IgM-type monoclonal) antibodies were described previously
(18). Anti-CLOCK (Bethyl Laboratories), anti-BMAL1 (Bethyl Laboratories),
anti-CRY2 (Bethyl Laboratories), anti-PER2 (Alpha Diagnostic International),
anti–Rev-Erbαα (NR1D1) (Cell Signaling Technology), anti–Rev-Erbβ (NR1D2)
(Santa Cruz Biotechnology), anti-MEK2 (BD Biosciences), and anti-Lamin A/C
(EMD Millipore) antibodies were obtained from commercial sources.
ChIP and mRNA Real-Time PCR. ChIP and mRNA real-time PCR were performed
as previous described with minimal modifications (15). Protein G Dynabeads
(Thermo Fisher Scientific) were used for purification of immune complexes,
and eluted DNA was purified using phenol-chloroform extraction and eth-
anol precipitation. Real-time PCR assays were performed using an ABI 7500
system (Applied Biosystems) using primers shown in Tables S3 and S4.
Real-time PCR assays measured expression of RNA following addition of
4-OHT. For each gene, in each cell line, the values for RNA expressed after
4-OHT addition were normalized to give the percent expression relative to
the level expressed at zero time. It should be noted that at zero time, the RNA
levels of some clock RNAs varied between cell lines, comparedwith expression
of control RNA (GAPDH). Thus, in Fig. 3A, Right, although all cell lines
showed a similar level of Cry1 RNA expression at zero time, in Bmal1−/− cells,
Cry1 RNA was expressed constitutively at a high level.
Library Generation and Next Generation Sequencing.
ChIP-seq. DNA libraries of input or BMAL1-ChIP from Per1/2−/−;Nr1d1/2−/−;
PER2-ER* cells with or without 4-OHT treatment (4 h) were made using
ThruPLEX DNA-seq Kit (RUBICON GENOMICS). Libraries were sequenced
using Illumina HiSEq. 2000 (1 × 50). Two independent experiments were
performed. The number of reads obtained from each sample was around
15–20 million.
RNA-seq. Total RNA was extracted from PN-P2ER cells with or without 4-OHT
treatment (4 h) using TRIzol RNA extraction (Thermo Fisher Scientific). After
phase separation, RNA was purified using the PureLink RNA Mini Kit (Thermo
Fisher Scientific). Librariesweremadeusing TruSeq strandedmRNApreparation
kit (Illumina) and sequenced using Illumina HiSEq. 2000 (1 × 50 × 2 lanes). The
number of reads obtained from each sample was around 80∼90 million.
Next Generation Sequencing Data Analysis. The sequences were trimmed to
remove adaptor sequences using BBDuk tool (bbmap/35.82) (36) using pa-
rameters “ktrim = r k = 23 hdist = 1 minlen = 50.”
ChIP-Seq analysis. Sequencing reads from each experiment were mapped to
the mouse genome (mm10) using Bowtie2/2.2.8 (37) using default parameters.
Low-quality reads were filtered using Samtools/1.3 (38) with option “-q 10.”
Enrichment regions (peaks) relative to the matching input control for each
experiment were determined using Callpeaks function in MACS/2015–04-20
(39) with options “-f BAM -g mm -B -q 0.01.” Given the peak regions called in
each experiment, we next determined the common peak regions using In-
tersect function in Bedtools/2.25.0 (40). From two experiments, 4,740 common
peak regions were determined in the condition without 4-OHT treatment, and
483 regions were determined in the condition with 4-OHT treatment. Because
the regions determined in the condition with 4-OHT treatment were included
in the regions determined in the condition without 4-OHT, we used these
4,740 regions for further quantitative analysis. To verify the specificity of our
data, we performed motif analysis of these regions by MEME-ChIP (41) and
the result showed high enrichment of the E-box sequence (CACGTG). To
compare with random regions from the genome, we generated random
regions with the same length distribution using the ShuffleBed function
in Bedtools/2.25.0.
To quantify the relative binding strength of BMAL1, we first tabulated the
number of unique mapping reads per region using BamtoBed and Intersect
functions (with option “-c”) in Bedtools/2.25.0. Then, the numbers were nor-
malized to number of reads per 10 million reads. We then determined the
relative peak binding strength, defined as (number of reads in ChIP + c)/
(number of reads in Input + c) in these regions. The constant “c” was used to
smooth fluctuations in fold change due to very small denominator values,
shrinking the fold change toward 1 for small counts. We chose c = 5 in this case
as a conservative measure.
RNA-Seq. Sequencing reads from each experiment were mapped to the mouse
genome (mm10) using bbmap/35.82 (36) with the option “maxindel = 100000
intronlen = 10 ambig = random qin = 33.”Mapped reads were quantified using
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featureCounts (42) with option “-T 4 -t exon.” Gene expression analysis was
performed using Deseq2 (43). To analyze CLOCK–BMAL1 controlled genes, the
transcription start sites of annotated genes were compared with the BMAL1
binding sites (extended to 10 kb) identified in our ChIP-seq using Intersect
functions in Bedtools/2.25.0. Data of annotated genes with a transcription start
site within 5 kb from a BMAL1 binding site were selected from the Deseq2
analysis and were shown by Volcano blot.
Reporter Gene Assay and Biotin-DNA Pull Down. The mouse Cry1 promoter
(1.5 kb from –1208 to +328) was amplified by PCR from genomic DNA of
PN-P2ER* cells using the primer sequences provided in a previous publication
(14). The amplified DNA fragment was cloned into pGL4.16 plasmid (Promega)
using NheI and XhoI. Two E-boxes identified in this region (AACGTG, CACGTG)
were mutated to AAGCTG and CAGCTG (mutE). D-boxes were mutated using
the published sequence (14) and plasmid mutE as template to generate
the mCry1 promoter with mutDE. Mutagenesis was performed by Q5
mutagenesis kit (NEB). Reporter gene assay was performed by transfection
of pGL4.16 (250 ng), pBind (50 ng), pcDNA3-mCry1 (50 ng), pcDNA3-mPER2
(100, 200, 400, and 800 ng), and pcDNA4-myc-his (to final 1,150 ng) into
NIH 3T3 cells in 24-well plates using Lipofetamine 3000 (Thermo Fisher
Scientific). After 24 h, reporter gene expression was analyzed using the
Dual-Luciferase Reporter Assay System (Promega).
For biotin–DNA pull-down analysis, the 1.5 kbp NheI–XhoI WT and mu-
tant Cry1 promoter fragments were first purified after NheI and EcoRV (next
to XhoI) digestion of the reporter plasmids. Biotin-11-dUTP was incorpo-
rated into the DNA fragments by fill-in of the 5′-overhangs of the NheI-
digested sites using exo− Klenow (NEB). DNA was purified by microSpin G50
column (GE Healthcare Life Sciences) and phenol-chloroform/ethanol pre-
cipitation to remove residual Biotin-dUTP. Binding of CLOCK–BMAL1 was
performed in 30 μL reactions with 600 ng of poly-dI:C, 30 μg of NIH 3T3 nuclear
extract, 0.33 M urea, 0.33% Nonidet P-40, 100 mM NaCl, and 300 fmol
biotin–DNA. After 30 min incubation on ice, 20 μL of each reaction was
mixed with 5 μL Dynabeads M280 streptavidin (Thermo Fisher Scientific)
and incubated for another 30 min with rotation. After washing with TE
buffer, BMAL1 was eluted with SDS sample buffer and detected by
Western blot.
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